BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 16842857)

  • 21. PTEN and SHIP2 regulates PI3K/Akt pathway through focal adhesion kinase.
    Gupta A; Dey CS
    Mol Cell Endocrinol; 2009 Oct; 309(1-2):55-62. PubMed ID: 19501627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inositol phosphatase SHIP2 negatively regulates insulin/IGF-I actions implicated in neuroprotection and memory function in mouse brain.
    Soeda Y; Tsuneki H; Muranaka H; Mori N; Hosoh S; Ichihara Y; Kagawa S; Wang X; Toyooka N; Takamura Y; Uwano T; Nishijo H; Wada T; Sasaoka T
    Mol Endocrinol; 2010 Oct; 24(10):1965-77. PubMed ID: 20829391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity.
    Vandeput F; Backers K; Villeret V; Pesesse X; Erneux C
    Cell Signal; 2006 Dec; 18(12):2193-9. PubMed ID: 16824732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.
    Mokhtari D; Al-Amin A; Turpaev K; Li T; Idevall-Hagren O; Li J; Wuttke A; Fred RG; Ravassard P; Scharfmann R; Tengholm A; Welsh N
    Diabetologia; 2013 Jun; 56(6):1327-38. PubMed ID: 23462796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SHIP2: an emerging target for the treatment of type 2 diabetes mellitus.
    Baumgartener JW
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):291-8. PubMed ID: 14683460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of insulin signaling and glucose transporter 4 (GLUT4) exocytosis by phosphatidylinositol 3,4,5-trisphosphate (PIP3) phosphatase, skeletal muscle, and kidney enriched inositol polyphosphate phosphatase (SKIP).
    Ijuin T; Takenawa T
    J Biol Chem; 2012 Mar; 287(10):6991-9. PubMed ID: 22247557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense oligonucleotides against the lipid phosphatase SHIP2 improve muscle insulin sensitivity in a dietary rat model of the metabolic syndrome.
    Buettner R; Ottinger I; Gerhardt-Salbert C; Wrede CE; Schölmerich J; Bollheimer LC
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1871-8. PubMed ID: 17327370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease.
    Ooms LM; Horan KA; Rahman P; Seaton G; Gurung R; Kethesparan DS; Mitchell CA
    Biochem J; 2009 Apr; 419(1):29-49. PubMed ID: 19272022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
    Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
    Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue.
    Kurlawalla-Martinez C; Stiles B; Wang Y; Devaskar SU; Kahn BB; Wu H
    Mol Cell Biol; 2005 Mar; 25(6):2498-510. PubMed ID: 15743841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTEN and Other PtdIns(3,4,5)P
    Csolle MP; Ooms LM; Papa A; Mitchell CA
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling.
    Ishihara H; Sasaoka T; Hori H; Wada T; Hirai H; Haruta T; Langlois WJ; Kobayashi M
    Biochem Biophys Res Commun; 1999 Jun; 260(1):265-72. PubMed ID: 10381377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose metabolism activation by SHIP2 inhibitors via up-regulation of GLUT1 gene in L6 myotubes.
    Suwa A; Kurama T; Yamamoto T; Sawada A; Shimokawa T; Aramori I
    Eur J Pharmacol; 2010 Sep; 642(1-3):177-82. PubMed ID: 20558154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of SH2-domain containing inositol phosphatase 2 (SHIP2) in insulin producing INS1E cells improves insulin signal transduction and induces proliferation.
    Grempler R; Leicht S; Kischel I; Eickelmann P; Redemann N
    FEBS Lett; 2007 Dec; 581(30):5885-90. PubMed ID: 18061583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5'-phosphatase 2) on insulin signaling and glucose metabolism in mice.
    Fukui K; Wada T; Kagawa S; Nagira K; Ikubo M; Ishihara H; Kobayashi M; Sasaoka T
    Diabetes; 2005 Jul; 54(7):1958-67. PubMed ID: 15983195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity.
    Polianskyte-Prause Z; Tolvanen TA; Lindfors S; Dumont V; Van M; Wang H; Dash SN; Berg M; Naams JB; Hautala LC; Nisen H; Mirtti T; Groop PH; Wähälä K; Tienari J; Lehtonen S
    FASEB J; 2019 Feb; 33(2):2858-2869. PubMed ID: 30321069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SHIP2 and its involvement in various diseases.
    Suwa A; Kurama T; Shimokawa T
    Expert Opin Ther Targets; 2010 Jul; 14(7):727-37. PubMed ID: 20536411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.
    Onnockx S; De Schutter J; Blockmans M; Xie J; Jacobs C; Vanderwinden JM; Erneux C; Pirson I
    J Cell Physiol; 2008 Jan; 214(1):260-72. PubMed ID: 17620296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SH2 domain-containing inositol 5-phosphatase (SHIP2) inhibition ameliorates high glucose-induced de-novo lipogenesis and VLDL production through regulating AMPK/mTOR/SREBP1 pathway and ROS production in HepG2 cells.
    Gorgani-Firuzjaee S; Meshkani R
    Free Radic Biol Med; 2015 Dec; 89():679-89. PubMed ID: 26456051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.